Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 065304/0975 | |
| Pages: | 4 |
| | Recorded: | 10/23/2023 | | |
Attorney Dkt #: | FCCC-106-NANTKWEST |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
5
|
|
Patent #:
|
NONE
|
Issue Dt:
|
10/29/2019
|
Application #:
|
15529848
|
Filing Dt:
|
05/25/2017
|
Publication #:
|
|
Pub Dt:
|
07/12/2018
| | |
PCT #:
|
US2016024318
|
Title:
|
GENETICALLY MODIFIED NK-92 CELLS AND MONOCLONAL ANTIBODIES FOR THE TREATMENT OF CANCER
|
|
|
Patent #:
|
|
Issue Dt:
|
08/11/2020
|
Application #:
|
16541847
|
Filing Dt:
|
08/15/2019
|
Publication #:
|
|
Pub Dt:
|
12/05/2019
| | | | |
Title:
|
GENETICALLY MODIFIED NK-92 CELLS AND MONOCLONAL ANTIBOIDES FOR THE TREATMENT OF CANCER
|
|
|
Patent #:
|
|
Issue Dt:
|
05/11/2021
|
Application #:
|
16903882
|
Filing Dt:
|
06/17/2020
|
Publication #:
|
|
Pub Dt:
|
10/01/2020
| | | | |
Title:
|
GENETICALLY MODIFIED NK-92 CELLS AND MONOCLONAL ANTIBOIDES FOR THE TREATMENT OF CANCER
|
|
|
Patent #:
|
|
Issue Dt:
|
12/28/2021
|
Application #:
|
17217839
|
Filing Dt:
|
03/30/2021
|
Publication #:
|
|
Pub Dt:
|
08/05/2021
| | | | |
Title:
|
GENETICALLY MODIFIED NK-92 CELLS AND MONOCLONAL ANTIBODIES FOR THE TREATMENT OF CANCER
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17530211
|
Filing Dt:
|
11/18/2021
|
Publication #:
|
|
Pub Dt:
|
03/03/2022
| | | | |
Title:
|
GENETICALLY MODIFIED NK-92 CELLS HAVING A SAFETY SWITCH
|
|
Assignee
|
|
|
333 COTTMAN AVENUE |
PHILADELPHIA, PENNSYLVANIA 19111 |
|
Correspondence name and address
|
|
KATHLEEN D. RIGAUT
|
|
325 SENTRY PARKWAY EAST
|
|
FIVE SENTRY EAST, SUITE 160
|
|
BLUE BELL, PA 19422
|
Search Results as of:
07/09/2025 11:28 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|